Season 2, Episode 19: Confronting Osteoporosis with Miranda Toledano

Season 2, Episode 19: Confronting Osteoporosis with Miranda ToledanoWelcome back to the Pharmaverse Podcast, hosted by Michael Pietrack. In this episode, we sit down with Miranda Toledano, CEO of EnteraBio (NASDAQ: ENTX), to explore:🔹 The evolving treatment paradigm for osteoporosis🔹 Why millions of women worldwide remain undiagnosed and untreated🔹 EnteraBio’s groundbreaking EV613 oral tablet—a potential game-changer versus injectables🔹 The FDA alignment milestone using Bone Mineral Density (BMD) as a primary endpoint🔹 Leadership lessons from Miranda’s Type A+++ drive, balance, and building passionate teams🔹 Career advice for young leaders: “Just keep going.”If you’re a leader, innovator, or aspiring professional in biotech, Pharma, or life sciences, this episode is packed with powerful insights that can transform your career.👉 Don’t forget to like, comment, and subscribe for more thought leadership conversations in the Pharma universe!𝐂𝐎𝐍𝐍𝐄𝐂𝐓 𝐖𝐈𝐓𝐇 𝐔𝐒:▶  Website: [https://www.kbic.com/recruiting/]▶  LinkedIn: [ https://www.linkedin.com/in/michaelpietrack]▶ Have you seen all of our playlists?                  [https://www.youtube.com/@ThePharmaversePodcast/playlists ]▶ Also, join the private LinkedIn Job Board: MSL Job Board